Search

everythinglearnresearchcommunity

for

Search:↓

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

The 5/G hydrogel effectively improves diabetic wound healing.

Cepharanthine shows promise as a natural anticancer treatment.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

QLT0267 stops hair follicle cell growth and movement.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Imatinib can cause hair loss due to lichen planopilaris.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

A lotion with tretinoin, minoxidil, and betamethasone valerate helped treat a woman's skin infection.

Oclacitinib effectively treated a diabetic cat's severe skin issues without raising glucose levels, and surgery fixed eyelid fusion.

Ruxolitinib treatment may cause eyelash growth.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

A man treated with gefitinib for lung cancer grew new hair on his bald scalp.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Upadacitinib improved multiple immune-related conditions in one patient.